Logotype for Haoxi Health Technology Limited

Haoxi Health Technology (HAO) Registration Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Haoxi Health Technology Limited

Registration Filing summary

29 Nov, 2025

Company overview and business model

  • Operates as an online marketing solution provider in China, primarily serving healthcare industry advertisers.

  • Offers one-stop online marketing services, focusing on short video ads, content production, and campaign optimization.

  • Utilizes proprietary data analysis software, “Bidding Compass,” to enhance ad placement efficiency and ROI.

  • Maintains direct and agent-based relationships with major media platforms, especially ByteDance’s Ocean Engine.

  • Has served approximately 2,000 advertisers since 2018, with a growing client base and strong industry focus.

Financial performance and metrics

  • Revenue for the six months ended December 31, 2023 was $23.50 million, up 157% from $9.16 million in the prior year period.

  • Net income for the same period was $760,198, a 70% increase from $447,046.

  • Fiscal year 2023 revenue was $28.23 million, up 75% from $16.16 million in 2022; net income was $969,752, up from $244,587.

  • Gross margin improved to 7.3% in FY2023 from 4.0% in FY2022, mainly due to direct contracts with Ocean Engine.

  • Cash and cash equivalents as of December 31, 2023 were $1.11 million; company expects negative operating cash flows as it scales.

Use of proceeds and capital allocation

  • Plans to use approximately 60% of net proceeds for working capital and general corporate purposes, including sales and marketing.

  • About 30% allocated for acquiring or investing in technologies, solutions, or businesses to enhance data analysis and customer return rates.

  • Remaining 10% intended for hiring experienced employees to strengthen internal controls and compliance.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more